Table 2.

Metal-based radionuclides (α and β⁻) for peptide receptor-targeted radionuclide therapy

Radionuclide	Production/availability	Decay	Eβ−/Eα(MeV)
Y-90	90Sr/90Y Generator	β−	β−, 2.27
Rh-105	Reactor	β− and γ	β−, 0.566, 0.248; γ, 0.3192
Pm-149	Reactor	β− and γ	β−, 1.072; γ, 0.286
Sm-153	Reactor	β− and γ	β−, 0.69, 0.64; γ, 0.1032, 0.0697
Ho-166	Reactor	β− and γ	β−, 1.855, 1.773; γ, 0.0806, 1.3794
Lu-177	Reactor	β− and γ	β−, 0.497; γ, 0.2084, 0.1129
Re-188	188W/188Re Generator	β− and γ	β−, 2.118, 1.962; γ, 0.155
Re-186	Reactor	β− and γ	β−, 1.071, 0.933; γ, 0.1372
At-211	Accelerator	EC, α, and γ	γ, 0.687, 0.6696; α, 5.868
Pb-212	224Ra/212Pb Generator	β− and γ	β−, 0.569, 0.335; γ, 0.3000, 0.2386
Bi-212	224Ra/212Bi Generator	β−, γ, and α	β−, 2.251; γ, 0.7273; α, 6.051
Bi-213	225Ac/213Bi Generator	β−, γ, and α	β−, 1.42, 1.02; γ, 0.4405, 0.3237; α, 5.87, 5.55